Amir Tehrani Co-Founded MaxQ Medical Raises $31.5M in Series A Funding

MaxQ Medical, a Sunnyvale, CA-based provider of a transurethral imaging and therapy platform for prostate care, has raised $31.5 million in a Series A financing round.

The round was led by Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures, with participation from Hillside Capital.

The company plans to use the funding to expand its team and advance its clinical program.

Funding Snapshot

About MaxQ Medical

Founded in 2023 by Amir Tehrani, MaxQ Medical is developing an automated, urethra-preserving ultrasound imaging and targeted therapy system for prostate care.

The company's platform is designed for outpatient procedures and combines advanced imaging with tissue selective therapy. It aims to allow urologists to see the prostate, and deliver individualized treatment during the same procedure.

Read More:Peter Morelli Co-Founded bitdrift Raises $15M in Total Funding

The companys initial focus is benign prostatic hyperplasia (BPH) with plans to expand into focal therapy for prostate cancer, and, eventually, broader prostate diagnostics.

Core offerings include:

• Transurethral ultrasound imaging
• Targeted prostate therapy
• Urethra-preserving treatment technology
• Prostate diagnostics and tumor mapping

Core Technologies / Products / Services